Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1 Colorectal Neoplasms 1

Interventions

Sorafenib 22 Bevacizumab 15 pembrolizumab 10 durvalumab 7 Nivolumab 7 Ipilimumab 6 Drug Therapy 6 atezolizumab 5 Talaporfin 5 spartalizumab 4 regorafenib 4 lenvatinib 4 derazantinib 3 Ramucirumab 3 Photochemotherapy 3 Leucovorin 3 Injections 3 Fluorouracil 3 Doxorubicin 3 tremelimumab 2 toripalimab 2 seocalcitol 2 relatlimab 2 phosphomannopentaose sulfate 2 liposomal doxorubicin 2 exatecan 2 cabozantinib 2 brivanib 2 Phototherapy 2 Oxaliplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Liver Neoplasms × Radionuclide Generators × Clear all

NCT00510627 2017-03-03

Prometheus

Boston Scientific Corporation

Phase 4 Withdrawn

Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡